Center Laboratories, Inc. (TPEX:4123)
Taiwan
· Delayed Price · Currency is TWD 37.75
-0.20 (-0.53%)
Apr 2, 2025, 10:32 AM CST
Center Laboratories Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1,618 | 1,394 | 767.72 | 500.11 | 717.05 | Upgrade
|
| Revenue Growth (YoY) | 16.06% | 81.58% | 53.51% | -30.25% | -50.13% | Upgrade
|
| Cost of Revenue | 868.92 | 775.91 | 361.45 | 240.45 | 366.75 | Upgrade
|
| Gross Profit | 748.95 | 618.09 | 406.27 | 259.66 | 350.3 | Upgrade
|
| Selling, General & Admin | 442.67 | 456.8 | 287.34 | 291.4 | 694.23 | Upgrade
|
| Research & Development | 71.96 | 82.76 | 47.02 | 75.4 | 128.87 | Upgrade
|
| Other Operating Expenses | - | - | -212.52 | 147.02 | - | Upgrade
|
| Operating Expenses | 514.89 | 539.54 | 122.15 | 513.81 | 822.08 | Upgrade
|
| Operating Income | 234.06 | 78.56 | 284.12 | -254.15 | -471.78 | Upgrade
|
| Interest Expense | -199.12 | -173.65 | -75.82 | -94.07 | -78.63 | Upgrade
|
| Interest & Investment Income | 175.02 | 332.1 | 201.78 | 222.01 | 44.13 | Upgrade
|
| Earnings From Equity Investments | -549.02 | -720.99 | -705.7 | 983.24 | 684.57 | Upgrade
|
| Currency Exchange Gain (Loss) | 76.95 | -1.4 | 319.61 | 5.15 | -8.37 | Upgrade
|
| Other Non Operating Income (Expenses) | 27.4 | -35.51 | 24.98 | 79.73 | 39.74 | Upgrade
|
| EBT Excluding Unusual Items | -234.71 | -520.89 | 48.97 | 941.91 | 209.65 | Upgrade
|
| Gain (Loss) on Sale of Investments | -935.33 | -590.64 | -637.85 | 1,654 | 5,788 | Upgrade
|
| Asset Writedown | - | -2.38 | -0.03 | - | - | Upgrade
|
| Pretax Income | -1,170 | -1,114 | -588.91 | 2,596 | 5,997 | Upgrade
|
| Income Tax Expense | -66.63 | -66.26 | -13.29 | 438.69 | 1,111 | Upgrade
|
| Earnings From Continuing Operations | -1,103 | -1,048 | -575.62 | 2,157 | 4,886 | Upgrade
|
| Minority Interest in Earnings | -0.28 | 52.23 | 677.84 | -340.77 | -1,100 | Upgrade
|
| Net Income | -1,104 | -995.42 | 102.22 | 1,816 | 3,786 | Upgrade
|
| Net Income to Common | -1,104 | -995.42 | 102.22 | 1,816 | 3,786 | Upgrade
|
| Net Income Growth | - | - | -94.37% | -52.03% | - | Upgrade
|
| Shares Outstanding (Basic) | 710 | 664 | 645 | 635 | 617 | Upgrade
|
| Shares Outstanding (Diluted) | 710 | 664 | 645 | 667 | 641 | Upgrade
|
| Shares Change (YoY) | 6.91% | 2.98% | -3.27% | 3.96% | 9.45% | Upgrade
|
| EPS (Basic) | -1.55 | -1.50 | 0.16 | 2.86 | 6.14 | Upgrade
|
| EPS (Diluted) | -1.55 | -1.50 | 0.16 | 2.78 | 5.94 | Upgrade
|
| EPS Growth | - | - | -94.29% | -53.20% | - | Upgrade
|
| Free Cash Flow | 239.21 | -1,133 | -197.16 | -365.69 | -341.29 | Upgrade
|
| Free Cash Flow Per Share | 0.34 | -1.71 | -0.31 | -0.55 | -0.53 | Upgrade
|
| Dividend Per Share | 0.750 | 1.500 | 0.910 | 1.985 | 1.083 | Upgrade
|
| Dividend Growth | -50.00% | 64.87% | -54.16% | 83.29% | 4.75% | Upgrade
|
| Gross Margin | 46.29% | 44.34% | 52.92% | 51.92% | 48.85% | Upgrade
|
| Operating Margin | 14.47% | 5.63% | 37.01% | -50.82% | -65.80% | Upgrade
|
| Profit Margin | -68.22% | -71.41% | 13.31% | 363.16% | 528.06% | Upgrade
|
| Free Cash Flow Margin | 14.79% | -81.27% | -25.68% | -73.12% | -47.60% | Upgrade
|
| EBITDA | 383.25 | 216 | 315.09 | -220.84 | -418.63 | Upgrade
|
| EBITDA Margin | 23.69% | 15.50% | 41.04% | -44.16% | -58.38% | Upgrade
|
| D&A For EBITDA | 149.19 | 137.44 | 30.97 | 33.31 | 53.15 | Upgrade
|
| EBIT | 234.06 | 78.56 | 284.12 | -254.15 | -471.78 | Upgrade
|
| EBIT Margin | 14.47% | 5.63% | 37.01% | -50.82% | -65.80% | Upgrade
|
| Effective Tax Rate | - | - | - | 16.90% | 18.52% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.